About Roger M. Perlmutter: Roger M. Perlmutter is the executive vice president of Merck & Co. and president of Merck Research Laboratories.
By acquiring Biovex, we're continuing the transformation of Amgen into a company that supports therapeutic oncology as well as supportive care oncology.
Throughout my career, as both a physician and a scientist, I have drawn inspiration from Merck's unwavering commitment to scientific excellence. Over time, this commitment has brought forth an unparalleled number of breakthrough medicines and vaccine...
